Baillie Gifford & Co
MED icon

Baillie Gifford & Co’s Medifast MED Stock Holding History

Baillie Gifford & Co’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-154
Closed -$16K – 386
2023
Q1 		$16K Buy
154
+16
+12% +$1.77K ﹤0.01% 360
2022
Q4 		$15.9K Buy
138
+17
+14% +$1.98K ﹤0.01% 364
2022
Q3 		$13K Sell
121
-12
-9% -$1.72K ﹤0.01% 382
2022
Q2 		$24K Buy
133
+13
+11% +$2.33K ﹤0.01% 324
2022
Q1 		$20K Buy
120
+10
+9% +$1.89K ﹤0.01% 365
2021
Q4 		$23K Hold
110
– – ﹤0.01% 362
2021
Q3 		$21K Sell
110
-19
-15% -$4.67K ﹤0.01% 368
2021
Q2 		$37K Sell
129
-5
-4% -$1.35K ﹤0.01% 302
2021
Q1 		$28K Buy
+134
New +$32.1K ﹤0.01% 305

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return